References
- Turner RC, Holman RR, Matthews DR, Oakes SF, Bassett PA, Stratton IM, Cull CA, Manley SE, Frighi V. UKPDS 08. Study design, progress and performance. Diabetologia. 1991; 34:877–90.
- UKPDS Group. UKPDS 33. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998; 352:837–53.
- Turner R, Cull C, Holman R. UKPDS 17. A nine-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med. 1996; 124:136–45.
- Turner RC, Cull CA, Frighi V, Holman RR. UKPDS 49. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus – Progressive requirement for multiple therapies. J Am Med Assoc. 1999; 281:2005–12.
- Gaede P, Vedel P, Larsen N, Jensen GVH, Parving H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348:383–93.
- Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care. 1995; 18:1113–23.
- Gerstein HC, Miller ME, Byington RP, Goff DCJr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RHJr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358:2545–59.
- Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358:2560–72.
- Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009; 360:129–39.
- Hu DS, Henderson JA, Welty TK, Lee ET, Jablonski KA, Magee MF, Robbins DC, Howard BV. Glycemic control in diabetic American Indians – Longitudinal data from the Strong Heart Study. Diabetes Care. 1999; 22:1802–7.
- El Kebbi IM, Ziemer DC, Cook CB, Miller CD, Gallina DL, Phillips LS. Comorbidity and glycemic control in patients with type 2 diabetes. Arch Intern Med. 2001; 161:1295–300.
- Olivarius NdF, Beck-Nielsen H, Andreasen AH, Horder M, Pedersen PA. Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ. 2001; 323:970–5.
- Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. Springer series in statistics. New York:Springer, 2002.
- Turner RC, Cull CA, Stratton IM, Manley SE, Kohner EM, Matthews DR, Neil HAW, Levy JC, Holman RR. Overview of 6 years’ therapy of type 2 diabetes – a progressive disease. Diabetes. 1995; 44:1249–58.
- Pringle M, Stewart-Evans C, Coupland C, Williams I, Allison S, Sterland J. Influences on control in diabetes mellitus: patient, doctor, practice, or delivery of care?. Br Med J. 1993; 306:630–4.
- Goudswaard AN, Stolk RP, Zuithoff P, Rutten GEHM. Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care. Eur J Epidemiol. 2004; 19:541–5.
- Rothenbacher D, Ruter G, Saam S, Brenner H. Younger patients with type 2 diabetes need better glycaemic control: results of a community-based study describing factors associated with a high HbA(1C) value. Br J Gen Pract. 2003; 53:389–91.
- Shorr RI, Franse LV, Resnick HE, Di Bari M, Johnson KC, Pahor M. Glycemic control of older adults with type 2 diabetes: Findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Geriatr Soc. 2000; 48:264–7.
- Meneilly GS, Dawson K, Tessier D. Alterations in glucose-metabolism in the elderly patient with diabetes. Diabetes Care. 1993; 16:1241–8.
- Golagiuri S, Cull CA, Holman RR. Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? UK prospective diabetes study 61. Diabetes Care. 2002; 25:1410–7.